The Valley Desk

NCT02580552 · Interventional trial

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Overall registry status Completed

Phase 1

Conditions Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Lymphocytic Leukemia (CLL), Cutaneous T-cell Lymphoma (CTCL), Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype, Mycosis Fungoides (MF)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov